A Study of GC101 TIL in Advanced Melanoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Melanoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Cancer Hospital, Beijing, China
Contact: Study coordinator (Jun Guo) · guoj307@126.com · +861088121122

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Advanced Solid Tumor · Metastatic Solid Tumor · Soft Tissue Sarcoma (STS)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Scottsdale, United States · Jacksonville, United States

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Advanced Endometrial Carcinoma · Advanced Head and Neck Squamous Cell Carcinoma · Advanced Malignant Solid Neoplasm

Abroad (travel likely)RecruitingPHASE1

Houston, United States

Neo-adjuvant Immunotherapy in Patients With Localized Melanoma

Cutaneous Melanoma, Stage III · Mucosal Melanoma

Abroad (travel likely)RecruitingPHASE2

Bordeaux, France · Lyon, France